Loading clinical trials...
Loading clinical trials...
A Controlled Trial of Citalopram Added to Methylphenidate in Youth With Severe Mood Dysregulation
Conditions
Interventions
Add-on citalopram following optimized methylphenidate
Add-on placebo following optimized methylphenidate
Locations
1
United States
National Institutes of Health Clinical Center, 9000 Rockville Pike
Bethesda, Maryland, United States
Start Date
November 17, 2008
Primary Completion Date
February 1, 2018
Completion Date
February 1, 2018
Last Updated
May 7, 2019
NCT06984809
NCT06831435
NCT06481033
NCT07088939
NCT06275217
NCT05832489
Lead Sponsor
National Institute of Mental Health (NIMH)
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions